Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| BFRI | 8-K | bullish | 7/10 | Biofrontera reported Q2 2026 net product revenue of $12.0M (+32.9% YoY), a net loss of $0.6M ($-0.05/share) vs a $5.3M l | Aug 13, 2026 |
| SSII | 8-K | mixed | 6/10 | SS Innovations reported Q2 2026 revenue of $13.9M, up 39.4% YoY, beating the $11.7M consensus estimate. However, the com | Aug 13, 2026 |
| FTLF | 8-K | mixed | 5/10 | FitLife Brands reported Q2 2026 revenue of $26.5M (+65% YoY, driven by the Irwin Naturals acquisition) and diluted EPS o | Aug 13, 2026 |
| HTCR | 8-K | bearish | 6/10 | HeartCore Enterprises reported Q2 2026 revenue of $321,000, up 71.6% YoY from $187,000, driven by software development s | Aug 13, 2026 |
| FATE | 8-K | neutral | 5/10 | Fate Therapeutics reported Q2 2026 results with a net loss of $0.25 per share, slightly beating the consensus estimate o | Aug 13, 2026 |
| PDSB | 8-K | bearish | 7/10 | PDS Biotech reported Q2 2026 EPS of -$0.18, a 42.1% miss vs consensus of -$0.13, and announced a strategic refocus to pr | Aug 13, 2026 |
| CING | 8-K | neutral | 4/10 | Cingulate reported Q2 2026 financial results with a net loss of $5.9M, widening from $5.0M a year ago, as SG&A expenses | Aug 13, 2026 |
| DWTX | 8-K | bearish | 6/10 | Dogwood Therapeutics reported Q2 2026 net loss of $11.5M ($0.34/share) vs $3.8M ($1.99/share) in Q2 2025, driven by a $9 | Aug 13, 2026 |
| LWAY | 8-K | bearish | 6/10 | Lifeway Foods reported record Q2 2026 net sales of $66.9M, up 24.1% YoY, marking the 27th consecutive quarter of growth. | Aug 13, 2026 |
| RENX | 8-K | bearish | 7/10 | RenX Enterprises reported Q2 2026 record revenue of $4.26M, up 7.5% sequentially, with the Logistics segment profitable | Aug 13, 2026 |
| AETN | 8-K | neutral | 5/10 | Aeternum Health, Inc. acquired an option to purchase a 50.1% stake in American Renaissance Minerals (ARM), which holds t | Aug 13, 2026 |
| PARA | 8-K | bearish | 7/10 | Banzai International issued an additional $1.1M senior secured convertible note and warrants to an institutional investo | Aug 13, 2026 |
| BJDX | 8-K | neutral | 4/10 | Bluejay Diagnostics reported Q2 2026 results, highlighting the completion of SYMON-II pivotal study enrollment (750 pati | Aug 13, 2026 |
| SCIA | 8-K | neutral | 3/10 | SCI Engineered Materials announced the resignation of CFO Shelby Yohn, who held the role since April 2026, and will tran | Aug 13, 2026 |
| AACB | 8-K | bearish | 8/10 | Artius II Acquisition Inc. (AACB) announced it will not complete a business combination within its required timeframe an | Aug 13, 2026 |
| HCWC | 8-K | bullish | 7/10 | Host Digital, the target of HCWC's pending merger, signed a 15-year take-or-pay lease with a major cloud infrastructure | Aug 13, 2026 |
| MNRO | 8-K | neutral | 2/10 | Monro, Inc. filed an 8-K reporting the results of its 2026 Annual Meeting of Shareholders and a declaration of a quarter | Aug 13, 2026 |
| ONDS | 8-K | neutral | 6/10 | Ondas reported record Q2 2026 revenue of $83.8M, a 13-fold YoY increase and 67% sequential growth, and raised its full-y | Aug 13, 2026 |
| VEEA | 8-K | bearish | 6/10 | VEEA entered into an At Market Issuance Sales Agreement with Roth Capital Partners to sell up to $4,353,000 of common st | Aug 13, 2026 |
| CXM | 8-K | neutral | 2/10 | Sprinklr appointed Jordi Ribas, Ph.D., President of Search & AI at Microsoft, to its Board of Directors, effective Augus | Aug 13, 2026 |
| IREN | 8-K | bullish | 7/10 | IREN announced that Microsoft has accepted delivery of Horizon 1, the first of four 50MW AI Cloud deployments under a fi | Aug 13, 2026 |
| SNDA | 8-K | bullish | 6/10 | Sonida Senior Living entered into a $380.0 million senior secured term loan with Ally Bank, refinancing its existing $12 | Aug 13, 2026 |
| RKLB | 425, 8-K | mixed | 6/10 | Rocket Lab announced a new $1.944 billion at-the-market (ATM) equity program to fund the Iridium acquisition, replacing | Aug 13, 2026 |
| LUCD | 8-K | mixed | 5/10 | Lucid Diagnostics reported Q2 2026 revenue of $1.5M, up 27% YoY from $1.2M, and processed 2,770 EsoGuard tests. The comp | Aug 13, 2026 |
| RMTI | 8-K | neutral | 2/10 | Rockwell Medical, Inc. filed an 8-K on August 13, 2026, disclosing an updated corporate presentation under Item 7.01 Reg | Aug 13, 2026 |
| COLL | 8-K | bullish | 5/10 | Collegium Pharmaceutical announced an accelerated share repurchase (ASR) agreement with Jefferies LLC to repurchase $50 | Aug 13, 2026 |
| BBT | 8-K | neutral | 4/10 | Beacon Financial Corp filed an 8-K with a fixed-income investor presentation covering Q2 2026 results. The presentation | Aug 13, 2026 |
| NMTC | 8-K | mixed | 5/10 | NeuroOne reported fiscal Q3 2026 product revenue of $2.0M (+16% YoY), slightly below the $2.5M consensus, with a net los | Aug 13, 2026 |
| SGRP | 8-K | bearish | 6/10 | SPAR Group reported Q2 2026 net income of $409K ($0.02/diluted share), returning to profitability from a ($1K) loss a ye | Aug 13, 2026 |
| CADL | 8-K | neutral | 4/10 | Candel Therapeutics reported Q2 2026 financial results with a net loss of $38.9M ($0.52/share), significantly wider than | Aug 13, 2026 |